Not yet recruiting
Breast cancer
Not yet recruitingStudy of ribociclib with drug combination in early breast cancer patients to test de‑escalated treatment strategies
Registered drugNo placebo
Study of ribociclib with drug combination in early breast cancer patients to test de‑escalated treatment strategies
Registered drugNo placebo
- Disease:Breast cancer
- Substances:AbemaciclibAnastrozole+13
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Abemaciclib
- Sponsor:Istituto Di Candiolo Fondazione Del Piemonte Per L'Oncologia IRCCS
